# Sartorius Stedim Biotech acquires WaterSep BioSeparations for up to $36M

Sartorius Stedim Biotech has acquired U.S.-based WaterSep BioSeparations LLC, a developer of hollow-fiber membrane devices for biopharmaceutical applications. The purchase price is approximately $27 million plus an earn-out of up to $9 million based on sales growth by 2023.

- Type: Acquisition
- Announced: 2020-12-09
- Where: Marlborough, Massachusetts, United States
- Value: $27.0M
- Status: completed
- Products: hollow-fiber membrane devices, pre-sterilized assemblies
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Sartorius Stedim Biotech](https://endata.com/companies/18725.md) (acquirer)
- [WaterSep BioSeparations](https://endata.com/companies/51734.md) (target)

## Sources

- [sartorius.com](https://www.sartorius.com/en/company/newsroom/corporate-news/613334-613334), 2020-12-09: "This acquisition nicely complements our current offering for cell and gene therapy applications, cell harvesting and various solutions for intensified bioprocessing."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.